Funding · Healthcare & Life Sciences
The Stack raises ₹5.5 Cr pre-seed funding led by OTP Ventures and Huddle Ventures
By Startup Enthusiast ·
- Date
- Company
- The Stack
- What it does
- science-backed supplements
- Kind
- Funding
- Amount
- ₹5.5 Cr
- Stage
- pre-seed
- Founded
- 2024
What they do
The Stack builds science-backed supplements using clinically studied ingredients and transparent formulations to address specific health needs like sleep…
What happened
The company raised ₹5.5 crore in a pre-seed funding round led by OTP Ventures and Huddle Ventures, with participation from a group of angel investors
Why it matters
The funds will be used to expand the product pipeline, build the early team, and improve brand and packaging
The details
- The Stack, a supplements brand, raised ₹5.5 crore in a pre-seed funding round led by OTP Ventures and Huddle Ventures, with participation from a group of angel investors.
- The company focuses on building science-backed supplements using clinically studied ingredients and transparent formulations to address specific health needs like sleep and gut health.
- The funds will be used to invest in research and development, expand the product pipeline, build the early team, and improve brand and packaging.
- Founded by Shreya Jain and Kshitij Rihal, the startup was inspired by the founders’ own experiences as consumers seeking globally benchmarked supplement quality in India.
- The startup identified gaps in formulation standards, ingredient sourcing, and manufacturing practices, prompting them to build a science-first brand tailored for informed Indian buyers.
The bigger picture
- The founders aim to build a trusted Indian supplements brand anchored in science, transparency, and consistent consumer outcomes.
- The company is currently focused on key health categories such as sleep and gut health, with plans to maintain a concentrated portfolio of well-researched products rather than chasing trend-led launches.
- Over the past 12 months, the startup reported strong unit economics, with select products scaling more than 40x within a year and follow-up rates of 35–50 per cent across mature cohorts, indicating repeat usage.
About the business
- The Stack builds science-backed supplements using clinically studied ingredients and transparent formulations to address specific health needs like sleep and gut health.
- The company focuses on solving specific health needs such as sleep and gut health.
- The startup identified gaps in formulation standards, ingredient sourcing, and manufacturing practices, prompting them to build a science-first brand tailored for informed Indian buyers.
- The company is currently focused on key health categories such as sleep and gut health, with plans to maintain a concentrated portfolio of well-researched products rather than chasing trend-led launches.
- The funds will be used to invest in R&D, expand the product pipeline, strengthen the early team, and enhance brand packaging.
What happens next
- The company plans to maintain a concentrated portfolio of well-researched products rather than chasing trend-led launches.
The deal
- Type
- funding
Investors
- OTP Ventures (lead)
- Huddle Ventures (lead)
Founders
- Shreya Jain, Co-founder
- Kshitij Rihal, Co-founder
About The Stack
- Product
- supplements brand focused on building high-quality, science-backed products using clinically studied global ingredients
- Customers
- Health-conscious consumers seeking research-backed nutritional and wellness supplements.
- How it makes money
- Sells dietary supplements and nutrition products directly to consumers through online channels and marketplaces.
- What sets it apart
- Utilizes globally sourced, clinically studied ingredients to create clean and transparent dietary formulations.
Other articles talking about it
More on The Stack
Same day
- Shadowfax shares slip on stock market debut27 January 2026 · IPO · ₹1,907 crore
- Drishti IAS reports revenue of Rs 364 crore and PAT of Rs 61 crore in FY2527 January 2026 · Results
- Taghash launches execution service for VC and PE firms27 January 2026 · Launch
- Navam Capital raises over 315 crore for its first fund27 January 2026 · New fund · >₹315 crore (~$35M)
- 4baseCare raises ₹90 crore in Series B27 January 2026 · Funding · ₹90 crore
- Nivaan Care raises $7 million in Series A to scale its pain management clinics27 January 2026 · Funding · $7M